World Health Organization "3 by 5" Target Treat 3 million by 2005.

Slides:



Advertisements
Similar presentations
Group III: Demand Forecasting
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Global Measles and Rubella Strategic Plan
World Health Organization
Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Working Together to Improve Global Health
Mexico International AIDS Conference Global Architecture of HIV/AIDS Financing Remarks by Joy Phumaphi, Vice President of the World Bank’s Human Development.
1 Jonathan Brown UNGASS HLM, New York, June 2008 Progress & Lessons Learned.
Childhood Pneumonia and Diarrhoea 3 Bottlenecks, barriers, and solutions: results from multicountry consultations focused on reduction of childhood pneumonia.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Elizabeth Lule Manager ACTafrica The World Bank’s Support to HIV/AIDS Programs in Africa.
Comprehensive M&E Systems
UN Prequalification: UNICEF Perspective 5 th UN Prequalification stakeholders meeting 11th February 2009.
Global Health Program Guiding Principles April 2002.
Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.
Total health ODA commitments, US$ Billions.
Call to governments: Boost innovation for neglected diseases Bernard Pécoul Executive Director MSF meeting 8 June 2005.
Tajikistan The Global Fund to Fight AIDS, Tuberculosis and Malaria Support to the Strategic Plan to Prevent HIV/AIDS Epidemics in Tajikistan. November.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
The Global Fund- structure, function and evolution February 18, 2008.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Ibero-American Road Safety Conference Madrid, February 23-24, World Bank Global Road Safety Facility.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
WHO-HIV Department Strategic Information Unit AIDS Medicines and Diagnostics Service Contribution to Access to medicines Technical Briefing Seminar, November.
Global Alliance against Chronic Respiratory Diseases GARD/NCD Action Plan & 2011 UN Summit on NCDs Niels H. Chavannes MD PhD Associate.
Presenter Name Date. Who We Are Global partnership founded on the premise that better health information means better decisions and better health Partners.
1 Introduction to the Clinton Foundation HIV/AIDS Initiative 12 July 2007 Africa Recruit.
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Philippe Chiliade, MD, MHA Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Implementing HIV Care & Treatment Progress.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
Donors, prize funds and patent pools. KEI & UNU- MERIT Maastricht Workshop on Medical Innovation Prizes January 28th-29th 2008 Michelle Childs, Head of.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
World Health Organization "3 by 5" Target Access to HIV/AIDS Medicines The 3x5 strategy WHO/EDM Technical Briefing Seminar.
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? November 2009, dar Es Salaam.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
The Bank’s Regional HIV/AIDS Strategies An Overview.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda November 2013.
The Multi-Country HIV/AIDS Program (MAP) for Africa Status and Findings Keith Hansen ACTafrica February 2005.
Zimbabwe’s shift towards treat all: national country context
How does teamwork improve value. Dr Nils E
Selected events related to the treatment of AIDS
Expanding ARV treatment in developing countries: Issues and Prospects
GARD/NCD Action Plan & 2011 UN Summit on NCDs
Building Efficiency Accelerator
22nd International AIDS Conference Amsterdam, 24 July 2018
Access to HIV/AIDS Medicines The 3x5 strategy
Consolidated Technical Support Plan for AIDS
WHO Global HIV/AIDS Staff Meeting
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The STOP TB Strategy – 2009 VISION: A TB-free world
Fabio Scano IUATLD Conference Paris, 2003
Deliver Ethiopia 7/27/2019.
Presentation transcript:

World Health Organization "3 by 5" Target Treat 3 million by 2005

World Health Organization "3 by 5" Target 38 million people living with HIV/AIDS worldwide 6 million people are in need of antiretroviral treatment (ART) 440,000 people have access to treatment 3 million people die every year because they can not get the treatment ART prolongs lives of people with HIV/AIDS enabling them to lead a productive life. ART makes HIV/AIDS a chronic and manageable disease, not a death sentence. What is "3 by 5" Target? The Goal: Provide access to treatment for all The Target: Treat 3 million people with AIDS, by the end of 2005

World Health Organization "3 by 5" Target High burden countries in need of ART, Nov 2003

World Health Organization "3 by 5" Target Yearly deaths as a factor of total in Introduction of Highly Active Antiretroviral Treatment (HAART) AIDS Deaths in Africa AIDS Deaths in Western Europe Source: Adapted from WHO/UNAIDS Statistics & HIV/AIDS Surveillance in Europe, End-year report 2001, No 66, CESES Widening Gap of AIDS Treatment 2003

World Health Organization "3 by 5" Target Treatment Works Dec 2002 Mar 2003

World Health Organization "3 by 5" Target "3 by 5" Strategic Areas Providing s ss simplified and standardized tools and guidelines on antiretroviral treatment Creating A AA AMDS - AIDS Medicines and Diagnostics Service to ensure effective and reliable supply of medicines and diagnostics Rapid identification, dissemination and application of new knowledge and successful strategies Urgent and sustained technical s ss support to countries P Providing assistance to countries for capacity building and training

World Health Organization "3 by 5" Target A Simple Two-Pronged Approach Country Driven Simplification of ART WHO Strategy to Support Global Efforts to Scale Up Treatment

World Health Organization "3 by 5" Target A Simple Two-Pronged Approach Country Driven Scale-up & treatment happens in country. It is country driven Government are responsible for the care and treatment of their citizens, including the poor and marginalized Multiple actors are involved in ART and with scale-up WHO provides technical support to governments Focus on UNAIDS "Three Ones" approach  One National Plan  One Coordinating Body  One Monitoring and Evaluation System

World Health Organization "3 by 5" Target Simplification A Simple Two-Pronged Approach Fixed Dose Combination (FDC) drugs simplify drug regimens WHO has established an AIDS Medicines and Diagnostics Service (AMDS) to help countries streamline procurement and supply AMDS links with the WHO Procurement, Quality and Sourcing Project (pre-qualification), assessing products and manufacturers, providing support on procurement

World Health Organization "3 by 5" Target AMDS in Focus A project of UNAIDS, WHO, UNICEF the World Bank and other partners The AMDS network supports with: Strategic information Stockpiles and pooled procurement Product selection Demand forecasting Market intelligence on sources, prices, raw materials Technical support for product selection, procurement, supply-management and local production Prequalification of ARVs and safety monitoring

World Health Organization "3 by 5" Target What is "3 by 5" Building On? Increased global political commitment and resources Simplified treatment and testing More affordable pricing of ARV drugs Build on lessons from developing and developed countries Use of ART scale up to strengthen health systems and accelerate prevention Opportunities Partners Experience

World Health Organization "3 by 5" Target What is "3 by 5" Building On? Opportunities Partners UN and international agencies, governments, donors, non-governmental organizations including faith based organizations, researchers, people living with HIV/AIDS, private sector, charitable foundations, and communities Experience

World Health Organization "3 by 5" Target What is "3 by 5" Building On? Opportunities Experience Partners Lessons learned in dealing with SARS, Polio, TB will be applied in addressing the world's worst health crisis: HIV/AIDS

World Health Organization "3 by 5" Target Countries $5.5 billion to scale-up treatment to reach the target of 3 million people WHO $218 million for WHO technical assistance, 85% to be spent in country Funding for "3 by 5"

World Health Organization "3 by 5" Target The Time to Act is Now " To deliver antiretroviral treatment to the millions who need it, we must change the way we think and change the way we act. Business as usual will not work. Business as usual means watching thousands of people die every single day.” LEE Jong-wook, Director-General

World Health Organization "3 by 5" Target "3 by 5" Make It Happen